Unit of Endocrinology and Diabetes, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3406. doi: 10.1002/dmrr.3406. Epub 2020 Sep 24.
To compare a Mediterranean diet (MED) with a high-fibre vegetarian diet (HFV) in terms of hunger-satiety perception through post-prandial assessment of appetite-related hormones glucagon-like peptide 1 (GLP-1) and oxyntomodulin, as well as self-rated visual analogue scale (VAS) quantification, in overweight/obese subjects with type 2 diabetes (T2D).
Twelve T2D subjects (Male to female ratio = 7:5), mean age 63 ± 8.5 years, were enrolled in a randomized, controlled, crossover study. Participants consumed an MED meal as well as an isocaloric meal rich in complex carbohydrate as well as an isocaloric MED meal in two different visits with a 1-week washout period between the two visits. Appetite ratings, glucose/insulin, and gastrointestinal hormone concentrations were measured at fasting and every 30' until 210' following meal consumption.
GLP-1 and oxyntomodulin levels were significantly higher following MED meal compared with HFV meals (210' area under the curve, p < 0.022 and p < 0.023, respectively). Both MED and HFV meal resulted in a biphasic pattern of GLP-1 and oxyntomodulin, although MED meal was related to a delayed, significantly higher second GLP-1 peak at 150' compared with that of HFV meal (p < 0.05). MED meal was related to lower glucose profile compared with HFV meal (p < 0.039), whereas we did not observe significant changes in terms of self-reported VAS scores and insulin trend.
In T2D overweight/obese subjects, an MED meal is more effective than a HFV meal in terms of post-prandial plasma glucose homoeostasis and GLP-1 and oxyntomodulin release. These changes were not confirmed by VAS appetite self-assessment over a 210' period.
通过评估餐后相关激素胰高血糖素样肽 1(GLP-1)和胆囊收缩素,以及自我评估视觉模拟量表(VAS)的定量,比较地中海饮食(MED)和高纤维素食饮食(HFV)对 2 型糖尿病(T2D)超重/肥胖患者的饥饿-饱腹感感知。
12 名 T2D 患者(男/女比例=7/5),平均年龄 63±8.5 岁,参加了一项随机、对照、交叉研究。参与者在两次就诊中分别食用 MED 餐和富含复杂碳水化合物的等热量餐,以及两种不同的 MED 餐,两次就诊之间有 1 周的洗脱期。在禁食和餐后每 30 分钟测量一次食欲评分、血糖/胰岛素和胃肠激素浓度,直到餐后 210 分钟。
与 HFV 餐相比,MED 餐可显著提高 GLP-1 和胆囊收缩素水平(210 分钟时曲线下面积,p<0.022 和 p<0.023)。MED 和 HFV 餐均导致 GLP-1 和胆囊收缩素呈双相模式,尽管 MED 餐与 HFV 餐相比,在 150 分钟时出现延迟、显著更高的第二 GLP-1 峰(p<0.05)。与 HFV 餐相比,MED 餐可降低血糖谱(p<0.039),而我们未观察到 VAS 评分和胰岛素趋势的显著变化。
在 T2D 超重/肥胖患者中,与 HFV 餐相比,MED 餐在餐后血糖稳态和 GLP-1 和胆囊收缩素释放方面更有效。这些变化在 210 分钟期间通过 VAS 食欲自我评估未得到证实。